首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Formulation and Evaluation of FSM-Alginate Beads of Vildagliptin
【24h】

Formulation and Evaluation of FSM-Alginate Beads of Vildagliptin

机译:维格列汀FSM-海藻酸盐微珠的配制与评价

获取原文
           

摘要

Many approaches have been immerged to prolong the residence time of the dosage forms at the absorption site .One among them is the development of oral controlled release mucoadhesive system. The present study aims to formulate and evaluate the effectiveness of FSM-Alginate beads of Vildagliptin in streptozotocin induced diabetic rats. In the present work, 6 formulations of Vildagliptin mucoadhesive beads (F1 to F6) were prepared by ionotropic gelation method. Fenugreek seed mucilage and sodium alginate was used as polymers and calcium chloride as cross linking agent. The beads containing drugs and excipients were subjected to various evaluation test such as Particle size distribution, Swelling index, Mucoadhesivity and Dissolution studies. Among all the formulations, F3 containing FSM and sodium alginate in the concentration of 0.6g and % DEE of 97.89 resulting in the highest drug release rate of 97.86% at the end of 10 h. Hence, it was considered as the optimized formulation.
机译:已经采取了许多方法来延长剂型在吸收部位的停留时间。其中之一是开发口服控释粘膜粘附系统。本研究旨在制定和评估维格列汀的FSM-藻酸盐微珠在链脲佐菌素诱导的糖尿病大鼠中的有效性。在本工作中,通过离子胶凝法制备了6种维格列汀粘膜粘附小球(F1至F6)。胡芦巴种子粘液和藻酸钠用作聚合物,氯化钙用作交联剂。对包含药物和赋形剂的珠进行各种评估测试,例如粒度分布,溶胀指数,粘膜粘附性和溶出度研究。在所有制剂中,F3含有FSM和藻酸钠,浓度为0.6g,DEE%为97.89,在10 h结束时最高药物释放率为97.86%。因此,它被认为是优化配方。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号